{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:06:41Z","timestamp":1778623601135,"version":"3.51.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-511x-13-135","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T11:04:40Z","timestamp":1408619080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Markers of increased cardiovascular risk in patients with chronic kidney disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Anna","family":"Gluba-Brz\u00f3zka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Michalska-Kasiczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Franczyk-Sk\u00f3ra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Nocu\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,21]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1172\/JCI0215748","volume":"110","author":"RR Singaraja","year":"2002","unstructured":"Singaraja RR, Fievet C, Castro G, James ER, Hennuyer N, Clee SM, Bissada N, Choy JC, Fruchart JC, McManus BM, Staels B, Hayden MR: Increased ABCA1 activity protects against atherosclerosis. J Clin Invest. 2002, 110: 35-42.","journal-title":"J Clin Invest"},{"key":"1156_CR2","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003, 108: 2154-2169.","journal-title":"Circulation"},{"key":"1156_CR3","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32: S112-S119.","journal-title":"Am J Kidney Dis"},{"key":"1156_CR4","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME: AHA statistical update heart disease and stroke statistics\u20142014 update. A report from the american heart association. Circulation. 2014, 129: e28-e292.","journal-title":"Circulation"},{"key":"1156_CR5","volume-title":"2002 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD","author":"US Renal Data System","year":"2002","unstructured":"US Renal Data System: 2002 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2002,"},{"key":"1156_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ki.1995.22","volume":"47","author":"RN Foley","year":"1995","unstructured":"Foley RN, Parfrey PS, Harnett JD: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995, 47: 186-192.","journal-title":"Kidney Int"},{"key":"1156_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3329\/bmrcb.v38i1.10447","volume":"38","author":"M Saha","year":"2012","unstructured":"Saha M, Faroque MO, Alam KS, Alam MM, Ahmed S: Chronic kidney disease specific cardiovascular risk factors among non dialytic patients with chronic kidney disease stage-V\u2013An experience of a specialized hospital Bangladesh. Med Res Counc Bull. 2012, 38: 18-22.","journal-title":"Med Res Counc Bull"},{"key":"1156_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1053\/ajkd.2002.29905","volume":"39","author":"MV Rocco","year":"2002","unstructured":"Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, Levey AS: Hemodialysis Study Group, The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration: Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. Am J Kidney Dis. 2002, 39: 146-153.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 5","key":"1156_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ndt\/15.suppl_5.69","volume":"15","author":"F Locatelli","year":"2000","unstructured":"Locatelli F, Marcelli D, Conte F, D\u2019Amico M, Del Vecchio L, Limido A, Malberti F, Spotti D: Registro Lombardo Dialisi e Trapianto: cardiovascular disease in chronic renal failure: the challenge continues. Nephrol Dial Transplant. 2000, 15 (Suppl 5): 69-80.","journal-title":"Nephrol Dial Transplant"},{"key":"1156_CR10","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","volume":"56","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community based cohort with mild renal insufficiency. Kidney Int. 1999, 56: 2214-2219.","journal-title":"Kidney Int"},{"key":"1156_CR11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.1998.00050.x","volume":"54","author":"C1 Duymelinck","year":"1998","unstructured":"Duymelinck C1, Deng JT, Dauwe SE, De Broe ME, Verpooten GA: Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int. 1998, 54: 804-","journal-title":"Kidney Int"},{"key":"1156_CR12","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1046\/j.1365-2168.2000.01499.x","volume":"87","author":"S Jain","year":"2000","unstructured":"Jain S, Bicknell GR, Nicholson ML: Molecular changes in extracellular matrix turnover after renal ischaemia-reperfusion injury. Br J Surg. 2000, 87: 1188-","journal-title":"Br J Surg"},{"issue":"3","key":"1156_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3949\/ccjm.73.3.289","volume":"73","author":"S Nurko","year":"2006","unstructured":"Nurko S: Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleve Clin J Med. 2006, 73 (3): 289-297.","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"1156_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrneph.2010.16","volume":"6","author":"A Gluba","year":"2010","unstructured":"Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J: The role of Toll-like receptors in renal diseases. Nat Rev Nephrol. 2010, 6 (4): 224-235.","journal-title":"Nat Rev Nephrol"},{"key":"1156_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2369-12-53","volume":"12","author":"A1 Mart\u00ednez-Castelao","year":"2011","unstructured":"Mart\u00ednez-Castelao A1, G\u00f3rriz JL, Portol\u00e9s JM, De Alvaro F, Cases A, Lu\u00f1o J, Navarro-Gonz\u00e1lez JF, Montes R, De la Cruz-Troca JJ, Natarajan A, Batlle D: Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol. 2011, 12: 53-","journal-title":"BMC Nephrol"},{"key":"1156_CR16","volume-title":"Chronic Kidney Disease, Stages 1\u20133. A guide to Clinical Practice","year":"2007","unstructured":"Chronic Kidney Disease, Stages 1\u20133. A guide to Clinical Practice. Edited by: Mahon A, Jenkins K. 2007, Luzern, Switzerland: EDTNA\/ERCA, 1,","edition":"1"},{"key":"1156_CR17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V1092029","volume":"10","author":"A Besarab","year":"1999","unstructured":"Besarab A, Frinak S, Yee J: An indistinct balance: the safety and efficacy of parenteral iron therapy. J Am Soc Nephrol. 1999, 10: 2029-2043.","journal-title":"J Am Soc Nephrol"},{"issue":"7\u20138","key":"1156_CR18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.20452\/pamw.745","volume":"119","author":"G Piecha","year":"2009","unstructured":"Piecha G, Adamczak M, Ritz M: Dyslipidemia in chronic kidney disease. Pathogenesis and intervention. Pol Arch Med Wewn. 2009, 119 (7\u20138): 487-492.","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"1156_CR19","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1016\/j.ijcard.2013.08.060","volume":"168","author":"D Nikolic","year":"2013","unstructured":"Nikolic D, Banach M, Nikfar S, Salari P, Mikhailidis DP, Toth PP, Abdollahi M, Ray KK, Pencina MJ, Malyszko J, Rysz J, Rizzo M: Lipid and blood pressure meta-analysis collaboration group: a meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?. Int J Cardiol. 2013, 168 (6): 5437-5447.","journal-title":"Int J Cardiol"},{"issue":"5","key":"1156_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1185\/03007995.2013.779237","volume":"29","author":"D Nikolic","year":"2013","unstructured":"Nikolic D, Nikfar S, Salari P, Rizzo M, Ray KK, Pencina MJ, Mikhailidis DP, Toth PP, Nicholls SJ, Rysz J, Abdollahi M, Banach M: Lipid and blood pressure meta-analysis collaboration group: effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Curr Med Res Opin. 2013, 29 (5): 435-451.","journal-title":"Curr Med Res Opin"},{"key":"1156_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18773\/austprescr.2010.016","volume":"33","author":"DM Roberts","year":"2010","unstructured":"Roberts DM, Singer RF: Management of renal bone disease. Aust Prescr. 2010, 33: 34-37.","journal-title":"Aust Prescr"},{"key":"1156_CR22","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1046\/j.1523-1755.1998.00154.x","volume":"54","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The long-term evolution of uremic cardiomyopathy. Kidney Int. 1998, 54: 1720-1725.","journal-title":"Kidney Int"},{"issue":"5","key":"1156_CR23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1681\/ASN.V1251079","volume":"12","author":"RJ Middleton","year":"2001","unstructured":"Middleton RJ, Parfrey PS, Foley RN: Left ventricular hypertrophy in the renal patient. JASN. 2001, 12 (5): 1079-1084.","journal-title":"JASN"},{"key":"1156_CR24","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","volume":"65","author":"C Zoccali","year":"2004","unstructured":"Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS: Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004, 65: 1492-1498.","journal-title":"Kidney Int"},{"key":"1156_CR25","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","volume":"12","author":"GM1 London","year":"2001","unstructured":"London GM1, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol. 2001, 12: 2759-2767.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1156_CR26","first-page":"225","volume":"29","author":"EB Arodiwe","year":"2010","unstructured":"Arodiwe EB, Ulasi II, Ijoma CK, Ike SO: Left ventricular diastolic function in a predialysis patient population. West Afr J Med. 2010, 29 (4): 225-229.","journal-title":"West Afr J Med"},{"issue":"1","key":"1156_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/HYPERTENSIONAHA.108.112334","volume":"52","author":"AYM Wang","year":"2008","unstructured":"Wang AYM, Wang M, Lam CWK, Chan IHS, Zhang Y, Sanderson JE: Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension. 2008, 52 (1): 107-114.","journal-title":"Hypertension"},{"issue":"2","key":"1156_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2169\/internalmedicine.51.6250","volume":"51","author":"Y Iwabuchi","year":"2012","unstructured":"Iwabuchi Y, Ogawa T, Inoue T, Otsuka K, Nitta K: Elevated E\/E\u2019 predicts cardiovascular events in hemodialysis patients with preserved systolic function. Intern Med. 2012, 51 (2): 155-160.","journal-title":"Intern Med"},{"issue":"3","key":"1156_CR29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.20452\/pamw.329","volume":"118","author":"T Zapolski","year":"2008","unstructured":"Zapolski T, Wysokinski A, Janicka L, Grzebalska A, Ksiazek A: Aortic stiffness and valvular calcifications in patients with end-stage renal disease. Pol Arch Med Wewn. 2008, 118 (3): 111-118.","journal-title":"Pol Arch Med Wewn"},{"issue":"suppl 113","key":"1156_CR30","first-page":"S1","volume":"76","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009, 76 (suppl 113): S1-S130.","journal-title":"Kidney Int"},{"key":"1156_CR31","first-page":"14","volume":"4","author":"L1 Janicka","year":"2006","unstructured":"Janicka L1, Czekajska-Chehab E, Duma D, Grzebalska AM, Mierzicki P, Or\u0142owska-Kowalik G, Solski J, Drop A, Ksiazek A: The study of some risk factors of coronary artery calcification in patients on peritoneal dialysis. Pol Arch Med Wewn. 2006, 4: 14-20. in polish,","journal-title":"Pol Arch Med Wewn"},{"issue":"3 Suppl 1","key":"1156_CR32","first-page":"S96","volume":"41","author":"M Relterowa","year":"2003","unstructured":"Relterowa M, Moe SM: Vascular calcification in dialysis patients: Pathogenesis and consequences. Am J Kidney Dis. 2003, 41 (3 Suppl 1): S96-S99.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1156_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12192-010-0214-x","volume":"16","author":"K Musial","year":"2011","unstructured":"Musial K, Zwolinska D: Matrix metalloproteinases (MMP-2, 9) and their tissue inhibitors (TIMP-1, 2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment. Cell Stress Chaperones. 2011, 16 (1): 97-103.","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"1156_CR34","first-page":"429","volume":"18","author":"Y Leskinen","year":"2009","unstructured":"Leskinen Y, Paana T, Saha H, Groundstroem K, Lehtim\u00e4ki T, Kilpinen S, Huhtala H, Airaksinen J: Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis. 2009, 18 (4): 429-438.","journal-title":"J Heart Valve Dis"},{"issue":"2","key":"1156_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1681\/ASN.2008040349","volume":"20","author":"KL Adeney","year":"2009","unstructured":"Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. JASN. 2009, 20 (2): 381-387.","journal-title":"JASN"},{"key":"1156_CR36","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1172\/JCI17351","volume":"110","author":"BM Brenner","year":"2002","unstructured":"Brenner BM: Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest. 2002, 110: 1753-1758.","journal-title":"J Clin Invest"},{"key":"1156_CR37","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"M Mizobuchi","year":"2009","unstructured":"Mizobuchi M, Towler D, Slatopolsky E: Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009, 20: 1453-1464.","journal-title":"J Am Soc Nephrol"},{"key":"1156_CR38","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London GM, Guerin AP, Marchais S, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003, 18: 1731-1740.","journal-title":"Nephrol Dial Transplant"},{"key":"1156_CR39","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001, 38: 938-942.","journal-title":"Hypertension"},{"key":"1156_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","volume":"14","author":"AY Wang","year":"2003","unstructured":"Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE: Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003, 14: 159-168.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1156_CR41","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s11255-013-0407-1","volume":"45","author":"S Olechnowicz-Tietz","year":"2013","unstructured":"Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J: The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol. 2013, 45 (6): 1605-1612.","journal-title":"Int Urol Nephrol"},{"issue":"164(2)","key":"1156_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijcard.2012.01.013","volume":"5","author":"A Gluba","year":"2013","unstructured":"Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M: Metabolic syndrome and renal disease. Int J Cardiol. 2013, 5 (164(2)): 141-150.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1156_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","volume":"27","author":"J Braun","year":"1996","unstructured":"Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kid Dis. 1996, 27 (3): 394-401.","journal-title":"Am J Kid Dis"},{"issue":"2","key":"1156_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1681\/ASN.2007080854","volume":"19","author":"SM Moe","year":"2008","unstructured":"Moe SM, Chen NX: Mechanisms of vascular calcification in chronic kidney disease. JASN. 2008, 19 (2): 213-216.","journal-title":"JASN"},{"key":"1156_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","volume":"84","author":"T1 Wada","year":"1999","unstructured":"Wada T1, McKee MD, Steitz S, Giachelli CM: Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res. 1999, 84: 166-178.","journal-title":"Circ Res"},{"issue":"1","key":"1156_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfq721","volume":"26","author":"MS Razzaque","year":"2011","unstructured":"Razzaque MS: Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism?. Nephrol Dial Transplant. 2011, 26 (1): 42-45.","journal-title":"Nephrol Dial Transplant"},{"key":"1156_CR47","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1210\/jcem-57-5-1028","volume":"57","author":"PD Delmas","year":"1983","unstructured":"Delmas PD, Wilson DM, Mann KG, Riggs BL: Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab. 1983, 57: 1028-1030.","journal-title":"J Clin Endocrinol Metab"},{"key":"1156_CR48","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice and onset osteoporosis and arterial calcification. Genes Dev. 1998, 12: 1260-1268.","journal-title":"Genes Dev"},{"key":"1156_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/CS20030126","volume":"105","author":"HP Jersmann","year":"2003","unstructured":"Jersmann HP, Dransfield I, Hart SP: Fetuin\/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci. 2003, 105: 273-278.","journal-title":"Clin Sci"},{"issue":"5","key":"1156_CR50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00580-011-1281-9","volume":"20","author":"IG Nessim","year":"2011","unstructured":"Nessim IG, Abd el Wahab A, Madani HA, Waked E, Abd el Khalek A, Mabrouk K: Evaluation of serum osteoprotegerin and fetuin A levels in Egyptian patients with chronic kidney disease. Comp Clin Pathol. 2011, 20 (5): 421-425.","journal-title":"Comp Clin Pathol"},{"key":"1156_CR51","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1523-1755.2005.00172.x","volume":"67","author":"R Mehrotra","year":"2005","unstructured":"Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, Gupta A, Norris K, Ketteler M, Adler S: Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 2005, 67: 1070-1077.","journal-title":"Kidney Int"},{"key":"1156_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI17202","volume":"112","author":"C Schafer","year":"2003","unstructured":"Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003, 112: 357-366.","journal-title":"J Clin Invest"},{"key":"1156_CR53","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","volume":"361","author":"M Ketteler","year":"2003","unstructured":"Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, B\u00f6hm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003, 361: 827-833.","journal-title":"Lancet"},{"key":"1156_CR54","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/ndt\/gfh891","volume":"20","author":"AY Wang","year":"2005","unstructured":"Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE: Association of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005, 20: 1676-1685.","journal-title":"Nephrol Dial Transplant"},{"key":"1156_CR55","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE, Shioi A, Morii HO: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000, 87: E10-E17.","journal-title":"Circ Res"},{"key":"1156_CR56","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2215\/CJN.02120508","volume":"6","author":"K Amann","year":"2008","unstructured":"Amann K: Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol. 2008, 6: 1599-1605.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1156_CR57","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0014-5793(02)02872-7","volume":"521","author":"J1 Zhang","year":"2002","unstructured":"Zhang J1, Fu M, Myles D, Zhu X, Du J, Cao X, Chen YE: PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. FEBS Lett. 2002, 521: 180-184.","journal-title":"FEBS Lett"},{"key":"1156_CR58","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1093\/ndt\/gfh263","volume":"19","author":"K1 Nitta","year":"2004","unstructured":"Nitta K1, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, Kabaya T, Nihei H: Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004, 19: 1886-1889.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1156_CR59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1681\/ASN.2005030260","volume":"17","author":"M Morena","year":"2006","unstructured":"Morena M, Terrier N, Jaussent I, Leray-Moragues H, Chalabi L, Rivory JP, Maurice F, Delcourt C, Cristol JP, Canaud B, Dupuy AM: Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol. 2006, 17 (1): 262-270.","journal-title":"J Am Soc Nephrol"},{"key":"1156_CR60","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1681\/ASN.2006080924","volume":"17","author":"K Matsubara","year":"2006","unstructured":"Matsubara K, Stenvinkel P, Qureshi AR, Carrero JJ, Axelsson J, Heimb\u00fcrger O, B\u00e1r\u00e1ny P, Alvestrand A, Lindholm B, Suliman ME: Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. Am Soc Nephrol. 2006, 17: 262-270.","journal-title":"Am Soc Nephrol"},{"key":"1156_CR61","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1161\/01.CIR.0000148367.08413.E9","volume":"110","author":"DM Basalyga","year":"2004","unstructured":"Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR: Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004, 110: 3480-3487.","journal-title":"Circulation"},{"issue":"2","key":"1156_CR62","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11255-009-9683-1","volume":"43","author":"J Rysz","year":"2011","unstructured":"Rysz J, Banach M, Stolarek RA, Mikhailidis DP, Cialkowska-Rysz A, Pokoca L, Piechota M, Baj Z: Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis. Int Urol Nephrol. 2011, 43 (2): 491-498.","journal-title":"Int Urol Nephrol"},{"issue":"Suppl 3","key":"1156_CR63","first-page":"23","volume":"90","author":"M Jeziorska","year":"2001","unstructured":"Jeziorska M: Transforming growth factor beta and CD105 expression in calcification and bone formation in human atherosclerotic lesions. Z Kardiol. 2001, 90 (Suppl 3): 23-26.","journal-title":"Z Kardiol"},{"key":"1156_CR64","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000151439","volume":"29","author":"M Nagano","year":"2008","unstructured":"Nagano M, Fukami K, Yamagishi S, Ueda S, Kaida Y, Matsumoto T, Yoshimura J, Hazama T, Takamiya Y, Kusumoto T, Gohara S, Tanaka H, Adachi H, Okuda S: Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease. Am J Nephrol. 2008, 29: 109-","journal-title":"Am J Nephrol"},{"issue":"3","key":"1156_CR65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000330175","volume":"34","author":"NX Chen","year":"2011","unstructured":"Chen NX, O\u2019Neill KD, Chen X, Kiattisunthorn K, Gattone VH, Moe SM: Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol. 2011, 34 (3): 211-219.","journal-title":"Am J Nephrol"},{"key":"1156_CR66","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1194\/jlr.M600218-JLR200","volume":"47","author":"AM Vaughan","year":"2006","unstructured":"Vaughan AM, Oram JF: ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J Lipid Res. 2006, 47: 2433-2443.","journal-title":"J Lipid Res"},{"issue":"12","key":"1156_CR67","first-page":"3900","volume":"117","author":"L1 Yvan-Charvet","year":"2007","unstructured":"Yvan-Charvet L1, Ranalletta M, Wang N, Han S, Terasaka N, Li R, Welch C, Tall AR: Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest. 2007, 117 (12): 3900-3908.","journal-title":"J Clin Invest"},{"key":"1156_CR68","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1172\/JCI8119","volume":"104","author":"RM Lawn","year":"1999","unstructured":"Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF: The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 1999, 104: R25-R31.","journal-title":"J Clin Invest"},{"key":"1156_CR69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cmet.2005.01.002","volume":"1","author":"MA Kennedy","year":"2005","unstructured":"Kennedy MA, Barrera GC, Nakamura K, Bald\u00e1n A, Tarr P, Fishbein MC, Frank J, Francone OL, Edwards PA: ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2005, 1: 121-131.","journal-title":"Cell Metab"},{"key":"1156_CR70","first-page":"149A","volume":"18","author":"G Deair","year":"2007","unstructured":"Deair G, Li Y, Liu D: Down regulation of cardiac renalase expression in CKD and protective effect of renalase in acute coronary syndrome. J Am Soc Nephrol. 2007, 18: 149A-","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1156_CR71","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/MNH.0b013e3282f521ba","volume":"17","author":"GV Desir","year":"2008","unstructured":"Desir GV: Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens. 2008, 17 (2): 181-185.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"1156_CR72","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0003319712459212","volume":"64","author":"J Malyszko","year":"2013","unstructured":"Malyszko J, Malyszko JS, Rysz J, Mysliwiec M, Tesar V, Levin-Iaina N, Banach M: Renalase, hypertension, and kidney - the discussion continues. Angiology. 2013, 64 (3): 181-187.","journal-title":"Angiology"},{"issue":"3","key":"1156_CR73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/HJH.0b013e32834f0bb7","volume":"30","author":"J Malyszko","year":"2012","unstructured":"Malyszko J, Malyszko JS, Mikhailidis DP, Rysz J, Zorawski M, Banach M: Hypertension and kidney disease: is renalase a new player or an innocent bystander?. J Hypertens. 2012, 30 (3): 457-462.","journal-title":"J Hypertens"},{"issue":"8","key":"1156_CR74","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ki.2010.488","volume":"79","author":"Y Wu","year":"2011","unstructured":"Wu Y, Xu J, Velazquez H, Wang P, Li G, Liu D, Sampaio-Maia B, Quelhas-Santos J, Russell K, Russell R, Flavell RA, Pestana M, Giordano F, Desir GV: Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2011, 79 (8): 853-860.","journal-title":"Kidney Int"},{"key":"1156_CR75","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI24066","volume":"115","author":"J Xu","year":"2005","unstructured":"Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV: Renalase is a novel soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005, 115: 1275-1280.","journal-title":"J Clin Invest"},{"issue":"6","key":"1156_CR76","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1097\/HJH.0b013e3283614638","volume":"31","author":"J Malyszko","year":"2013","unstructured":"Malyszko J, Koc-Zorawska E, Banach M, Mysliwiec M: Letter on 'sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney'. J Hypertens. 2013, 31 (6): 1272-1273.","journal-title":"J Hypertens"},{"key":"1156_CR77","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","volume":"95","author":"SM Moe","year":"2004","unstructured":"Moe SM, Chen NX: Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004, 95: 560-567.","journal-title":"Circ Res"},{"key":"1156_CR78","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/01.RES.0000161997.24797.c0","volume":"96","author":"CM Giachelli","year":"2005","unstructured":"Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H: Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res. 2005, 96: 717-722.","journal-title":"Circ Res"},{"issue":"6","key":"1156_CR79","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.5114\/aoms.2013.39792","volume":"9","author":"B Franczyk-Sk\u00f3ra","year":"2013","unstructured":"Franczyk-Sk\u00f3ra B, Gluba A, Banach M, Rysz J: Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease. Arch Med Sci. 2013, 9 (6): 1019-1027.","journal-title":"Arch Med Sci"},{"issue":"5","key":"1156_CR80","first-page":"636","volume":"19","author":"K Cagli","year":"2010","unstructured":"Cagli K, Basar N, Cagli K, Armutcu F, Aylak F, Yalcinkaya A, Erden G, Kadirogullari E: Association of serum fetuin-A with valvular calcium concentration in rheumatic mitral valve disease. J Heart Valve Dis. 2010, 19 (5): 636-643.","journal-title":"J Heart Valve Dis"},{"issue":"1","key":"1156_CR81","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5114\/aoms.2012.27294","volume":"8","author":"N Yilmaz","year":"2012","unstructured":"Yilmaz N: Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Arch Med Sci. 2012, 8 (1): 138-153.","journal-title":"Arch Med Sci"},{"issue":"5","key":"1156_CR82","doi-asserted-by":"publisher","first-page":"837","DOI":"10.5114\/aoms.2012.30834","volume":"9","author":"M Pietrzak-Nowacka","year":"2013","unstructured":"Pietrzak-Nowacka M, Safranow K, Bober J, Olszewska M, Birkenfeld B, Nowosiad M, Ciechanowski K: Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function. Arch Med Sci. 2013, 9 (5): 837-842.","journal-title":"Arch Med Sci"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-13-135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T09:03:05Z","timestamp":1746349385000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-13-135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,21]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-13-135","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,21]]},"assertion":[{"value":"15 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"135"}}